Your session is about to expire
← Back to Search
Exercise and Behavioral Training for Pancreatic Cancer
N/A
Waitlist Available
Led By Matthew H. Katz, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Scheduled to receive preoperative therapy (chemotherapy, radiation or chemoradiation) either on- or off-protocol
Pancreatic cancer of any type, biopsy-proven
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change compared from baseline to date surgery is scheduled
Awards & highlights
Study Summary
This trial is for people with pancreatic cancer who are scheduled to get chemotherapy and/or radiation before surgery. Researchers want to see if regular exercise and behavioral skills training can help improve physical activity for these patients.
Who is the study for?
This trial is for individuals with any type of biopsy-proven pancreatic cancer, who are set to receive pre-surgery chemotherapy and/or radiation. Participants must understand the study, be willing to maintain exercise logs, have phone or email access for communication, and not start surgery within 6 weeks from joining.Check my eligibility
What is being tested?
The PancFit study tests if a program combining regular exercise and behavioral skills training can boost physical activity in pancreatic cancer patients awaiting standard-of-care surgery after chemo/radiation therapy. It includes questionnaires, counseling, and physical assessments.See study design
What are the potential side effects?
Since this trial involves exercise and nutritional guidance rather than medication or invasive procedures, side effects may include typical exercise-related issues such as muscle soreness or strain. Nutritional changes could also cause digestive adjustments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am scheduled for preoperative therapy, including chemotherapy or radiation.
Select...
My pancreatic cancer diagnosis was confirmed through a biopsy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change compared from baseline to date surgery is scheduled
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change compared from baseline to date surgery is scheduled
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in 6 Minute Walk Test (6MWT)
Trial Design
2Treatment groups
Experimental Treatment
Group I: Arm B: Multi-Modal Exercise and Nutrition Program (MMENP)Experimental Treatment5 Interventions
After completion of chemotherapy and/or radiation, 3-6 weeks after surgery, then 3-7 months after surgery: Participants complete 4 questionnaires about physical abilities, motivation, and quality of life. Participant's hand grip strength measured. Participants arm strength measured. Participants asked to rise from a chair without using their arms to push off. Participants complete a 6-minute walk test to see how far participant can walk in 6 minutes. Participants complete a nutritional questionnaire and receive nutritional counseling. Participants receive educational materials and personalized counseling based on participant's answers.
Participants complete moderate-intensity aerobic exercise 5 days each week. Participants complete strength training exercises 2 times per week.
Participants contacted by phone by member of study staff 1 time each week for the first 4 weeks, and then every 2 weeks after that for behavioral skills training and to see how participant is doing.
Group II: Arm A: Standard of Care (SOC)Experimental Treatment4 Interventions
After completion of chemotherapy and/or radiation, 3-6 weeks after surgery, and then 3-7 months after surgery: Participants complete 4 questionnaires about physical abilities, motivation, and quality of life. Participant's hand grip strength measured. Participants arm strength measured using an arm curl test. Participants asked to rise from a chair without using their arms to push off. Participants complete a 6-minute walk test to see how far participant can walk in 6 minutes. Participants complete a nutritional questionnaire and receive nutritional counseling. Participants receive educational materials and personalized counseling based on participant's answers.
Participants encouraged to remain active during chemotherapy and/or radiation. Participants receive a booklet that contains a stretching guide with full-body stretches and safety.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Questionnaires
2013
Completed Phase 2
~3030
Phone Calls
2015
Completed Phase 2
~430
Find a Location
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
2,965 Previous Clinical Trials
1,804,765 Total Patients Enrolled
Matthew H. Katz, MDPrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
75 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My pain level is 7 or higher on a scale of 1 to 10.My cancer has come back after surgery.I have a muscle or joint disease that affects my ability to move.I am scheduled for preoperative therapy, including chemotherapy or radiation.I do not have severe heart or lung problems.I have neuroendocrine cancer.My pancreatic cancer diagnosis was confirmed through a biopsy.I have finished my pre-surgery treatment and am now in my rest period before surgery.I cannot put full weight on all my limbs due to a recent injury or fracture.I am expected to have surgery to remove my pancreas in 6 weeks or more from now.
Research Study Groups:
This trial has the following groups:- Group 1: Arm B: Multi-Modal Exercise and Nutrition Program (MMENP)
- Group 2: Arm A: Standard of Care (SOC)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still openings for enrollees in this experimental study?
"As per the information from clinicaltrials.gov, this medical trial is not open for recruitment at present. Though first posted on June 13th 2017 and last updated 8/2/2022, it has since been closed to new participants; however there are currently 700 other trials actively seeking enrollees."
Answered by AI
Share this study with friends
Copy Link
Messenger